Capitolis Liquid Global Markets LLC Purchases New Stake in AvePoint, Inc. $AVPT

Key Points

• Capitolis Liquid Global Markets LLC acquired a new position of 314,100 shares of AvePoint (≈$4.72M), representing about 0.15% of the company.
• AvePoint reported quarterly EPS $0.07 (missed estimates by $0.02) while revenue of $114.69M beat expectations, and analysts hold a Moderate Buy consensus with an average price target of $17.11 amid recent target cuts.
• Institutional investors own roughly 44.49% of AvePoint and insiders about 26.19%; Chairman Xunkai Gong sold 27,998 shares in January.

Capitolis Liquid Global Markets LLC acquired a new position in shares of AvePoint, Inc. (NASDAQ:AVPT - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 314,100 shares of the company's stock, valued at approximately $4,715,000. Capitolis Liquid Global Markets LLC owned approximately 0.15% of AvePoint as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. AQR Capital Management LLC increased its stake in shares of AvePoint by 118.5% in the 1st quarter. AQR Capital Management LLC now owns 323,055 shares of the company's stock worth $4,665,000 after acquiring an additional 175,194 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of AvePoint by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 76,639 shares of the company's stock valued at $1,107,000 after acquiring an additional 3,340 shares during the last quarter. Dynamic Technology Lab Private Ltd purchased a new stake in shares of AvePoint in the first quarter valued at about $276,000. Goldman Sachs Group Inc. grew its holdings in shares of AvePoint by 11.2% in the first quarter. Goldman Sachs Group Inc. now owns 759,647 shares of the company's stock valued at $10,969,000 after purchasing an additional 76,403 shares during the period. Finally, Focus Partners Wealth acquired a new stake in AvePoint during the first quarter worth about $737,000. Institutional investors and hedge funds own 44.49% of the company's stock.

AvePoint Price Performance

NASDAQ AVPT opened at $10.43 on Monday. The stock has a market capitalization of $2.25 billion, a P/E ratio of 65.19 and a beta of 1.12. The firm's 50-day moving average is $11.54 and its two-hundred day moving average is $13.34. AvePoint, Inc. has a 12 month low of $9.85 and a 12 month high of $20.25.

AvePoint (NASDAQ:AVPT - Get Free Report) last announced its quarterly earnings results on Thursday, February 26th. The company reported $0.07 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by ($0.02). The company had revenue of $114.69 million for the quarter, compared to analyst estimates of $110.94 million. AvePoint had a net margin of 8.34% and a return on equity of 8.19%. As a group, analysts anticipate that AvePoint, Inc. will post -0.03 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Cantor Fitzgerald reduced their target price on shares of AvePoint from $18.00 to $15.00 and set an "overweight" rating on the stock in a research note on Friday, February 27th. B. Riley Financial cut their price target on shares of AvePoint from $25.00 to $22.00 and set a "buy" rating for the company in a report on Monday, February 2nd. DA Davidson reduced their price target on shares of AvePoint from $20.00 to $18.00 and set a "buy" rating on the stock in a research report on Thursday, February 19th. TD Cowen decreased their price objective on AvePoint from $17.00 to $16.00 and set a "buy" rating on the stock in a report on Friday, February 27th. Finally, Zacks Research lowered AvePoint from a "strong-buy" rating to a "hold" rating in a research report on Friday, January 9th. Ten investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, AvePoint has an average rating of "Moderate Buy" and an average price target of $17.11.

Insider Transactions at AvePoint

In other AvePoint news, Chairman Xunkai Gong sold 27,998 shares of the company's stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $13.39, for a total transaction of $374,893.22. Following the transaction, the chairman directly owned 14,920,668 shares in the company, valued at $199,787,744.52. This represents a 0.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 26.19% of the stock is currently owned by insiders.

About AvePoint

AvePoint, Inc NASDAQ: AVPT is a leading software provider specializing in data management, governance, and compliance solutions for Microsoft 365 and related cloud platforms. Founded in 2001 and headquartered in Jersey City, New Jersey, the company offers a comprehensive suite of cloud-based and on-premises tools designed to help organizations migrate, manage, and protect their collaboration data. AvePoint's flagship Cloud Platform delivers backup, governance, reporting, and migration services for SharePoint, Teams, Exchange, OneDrive, and Salesforce environments.

With a customer base spanning thousands of organizations across more than 100 countries, AvePoint serves enterprises, government agencies, and educational institutions seeking to ensure data security, regulatory compliance, and operational resilience.

Want to see what other hedge funds are holding AVPT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for AvePoint, Inc. (NASDAQ:AVPT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.